The Michael J. Fox Foundation for Parkinson’s Research has chosen Northwestern to receive an Edmond J. Safra Fellowship in Movement Disorders to train a movement disorder clinician-investigator.
Menu
Browsing: Neurology
Exposure to even moderate ambient lighting during nighttime sleep, harms cardiovascular function during sleep and increases your insulin resistance, according to a new study.
Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment.
Of the more than 20 episodes of the medical school’s Breakthroughs podcast produced in 2021, the most popular ranged across specialties from gastroenterology to nanotechnology. Listen to the top five episodes of the year and earn Continuing Medical Education credit.
Yvette Wong, PhD, assistant professor in the Ken and Ruth Davee Department of Neurology, has received the NIH Director’s New Innovator Award, which supports early-career investigators conducting unconventional and innovative research projects in the biomedical, behavioral or social sciences.
Phyllis Zee, MD, PhD, GME ’87, has received the Lifetime Achievement Award from the National Sleep Foundation for her contributions to sleep medicine and the public health mission of the foundation.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
Shi-Yuan Cheng, PhD, professor in The Ken and Ruth Davee Department of Neurology in the Division of Neuro-oncology, has been named a fellow of the American Association for the Advancement of Science (AAAS) for his outstanding contributions to molecular and translational cancer research.
Tanya Simuni, MD, director of the Parkinson’s Disease and Movement Disorders Center, has received a multimillion-dollar grant from The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression for use in clinical trials for novel therapies.
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.